InvestorsHub Logo

creede

12/30/21 9:56 PM

#20035 RE: Bearslayer #20033

Nice find.

This play really does have huge potential.

glenngroove

12/30/21 11:12 PM

#20036 RE: Bearslayer #20033

Thanks for sharing just another feather in our cap

timez1000

12/31/21 5:51 AM

#20037 RE: Bearslayer #20033

Nice! Their patent portfolio alone should value this well over $100 million market cap. Compare to other clinical stage biopharma stocks like Myovant and Tarsus trading on NYSE and Nasdaq. Vyome has a larger patent portfolio than both of those companies. Expecting a massive move toward a proper valuation when all comes to light.

Bj106

12/31/21 6:50 AM

#20038 RE: Bearslayer #20033

Thanks Bearslayer. Great news!

46er

12/31/21 10:02 AM

#20039 RE: Bearslayer #20033

Excellent. Huge potential price run up.

skichic

12/31/21 10:08 AM

#20041 RE: Bearslayer #20033

Great find Bearslayer, thanks for the excellent DD!

TimeFades

12/31/21 10:37 AM

#20043 RE: Bearslayer #20033

Nice one